MedPath

Ayurvedic management of female infertility

Phase 3
Conditions
Health Condition 1: N970- Female infertility associated withanovulation
Registration Number
CTRI/2022/03/040864
Lead Sponsor
Director ITRA Jamnagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Female Patients of reproductive age >= 20 and <=40 years

Patients having overweight (BMI 25-29 Kg/M2 ) or obese (BMI >30 Kg/M2)

Patients who have completed active married life of minimum1-year duration and suffering from Infertility with 2 or more consecutive anovulatory cycles.

Both Primary and secondary infertile patients having anovulatory cycle or with immature ovarian follicle.

Patient eligible& willing for Basti

Patients willing to participate in trial

Exclusion Criteria

Female Patients having age < 20years and >40years.

Patient with infectious diseases of reproductive tract like tuberculosis, sexually transmitted diseases

Organic lesions of reproductive tract like tuberculosis, carcinoma and congenital deformities.

Patients with history of cardiac diseases, Uncontrolled Diabetes (above 200 mg/dl- RBS) & Hypertension (Systolic BP above 160 & Diastolic above 100mmhg), TB, etc.

Patient with Hepatitis C, Hepatitis B

Patient not eligible for Basti

Pitta dominant Prakruti patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
It is expected that the trial drugs will induce the ovulation.Timepoint: 3 months
Secondary Outcome Measures
NameTimeMethod
Trail drugs will cure menstrual abnormalities associated with anovulation like irregular, scanty menstruation, dysmenorrhoea <br/ ><br>It is expected that drugs will help to reduce BMI of patient. <br/ ><br> <br/ ><br>Timepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath